SEC 13F Intelligence

Brookstone Capital Management / LLY

Brookstone Capital Management’s Eli Lilly & Co Position

Does Brookstone Capital Management own Eli Lilly & Co (LLY)? Yes — 40.2K shares worth $37M (+0.42% of its 13F portfolio) as of Q1 2026, down from 41.8K shares the prior filed quarter.

Position Value
$37M
Q1 2026
Shares
40.2K
% of Portfolio
+0.42%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $1MQ2 ’19: $1MQ3 ’19: $1MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $3MQ2 ’21: $6MQ3 ’21: $7MQ4 ’21: $7MQ4 ’21Q1 ’22: $9MQ2 ’22: $12MQ3 ’22: $9MQ4 ’22: $9MQ4 ’22Q1 ’23: $9MQ2 ’23: $10MQ3 ’23: $13MQ4 ’23: $14MQ4 ’23Q1 ’24: $22MQ2 ’24: $28MQ3 ’24: $29MQ4 ’24: $29MQ4 ’24Q1 ’25: $30MQ2 ’25: $33MQ3 ’25: $35MQ4 ’25: $45MQ4 ’25Q1 ’26: $37Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202640.2K$37M+0.42%
Q4 202541.8K$45M+0.51%
Q3 202546.3K$35M+0.42%
Q2 202541.8K$33M+0.43%
Q1 202536.3K$30M+0.43%
Q4 202437.3K$29M+0.42%
Q3 202433.0K$29M+0.43%
Q2 202430.9K$28M+0.46%
Q1 202428.4K$22M+0.39%
Q4 202323.9K$14M+0.27%
Q3 202322.7K$13M+0.30%
Q2 202322.7K$10M+0.21%
Q1 202323.1K$9M+0.17%
Q4 202225.8K$9M+0.19%
Q3 202228.6K$9M+0.21%
Q2 202235.5K$12M+0.26%
Q1 202229.0K$9M+0.18%
Q4 202127.3K$7M+0.12%
Q3 202128.2K$7M+0.12%
Q2 202124.3K$6M+0.10%
Q1 202116.2K$3M+0.12%
Q4 202014.4K$2M+0.10%
Q3 202013.3K$2M+0.09%
Q2 202011.6K$2M+0.12%
Q1 202011.7K$2M+0.09%
Q4 201911.6K$2M+0.08%
Q3 201911.2K$1M+0.07%
Q2 201910.9K$1M+0.07%
Q1 201910.3K$1M+0.09%
Q4 201810.5K$1M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brookstone Capital Management’s full portfolio or all institutional holders of LLY.